Oct. 19, 2010 |
|
Mar. 03, 2020 |
|
jRCT1090220049 |
Clinical effect of multidisciplinary respiratory rehabilitation including nutrition support with BCAA and herbal medicine |
|
Clinical effect of multidisciplinary respiratory rehabilitation including nutrition support with BCAA and herbal medicine |
Hiroaki Harada |
||
National Hospital Organization Kure Medical Center, Chugoku Cancer Center |
||
3-1 Aoyama-machi, Kure, Hiroshima |
||
+81-823-22-3111 |
||
Hiroaki Harada |
||
National Hospital Organization Kure Medical Center, Chugoku Cancer Center |
||
3-1 Aoyama-machi, Kure, Hiroshima |
||
+81-823-22-3111 |
||
haradah@kure-nh.go.jp |
COMPLETED |
Sept. 01, 2010 |
||
100 | ||
Interventional |
||
prospective clinical study for checking efficacy and safety |
||
open(masking not used) |
||
No |
||
N/A |
||
Lung cancer patients with poor lung function meeting at least one of the following criteria: |
||
1) Severe mental disease or orthopedic disease |
||
20age old over | ||
89age old under | ||
Both |
||
Respiratory disease. |
||
Intervention type:DRUG,BEHAVIOUR Name of intervention:harbel medicine (Hochuekkitou),nutrition support (Branched Chain Amino Acid) Dose form / Japanese Medical Device Nomenclature:POWDER,NOT APPLICABLE Route of administration / Site of application:ORAL,ORAL Dose per administration:2.5,3.2 g g,g Dosing frequency / Frequency of use:TID,BID Planned duration of intervention:2 to 5 weeks ,2 to 5 weeks Intended dose regimen: detailes of teratment arms: Comparative intervention name: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use: Planned duration of intervention: Intended dose regimen: |
||
morbidity |
||
respiratory function, nutrition status, ADL and QOL, adverse effect |
Hiroaki Harada | |
National Hospital Organization |
Yes | |
JMA-IIA00049 | |
Japan |